Gamma-aapeptides with potent and broad-spectrum antimicrobial activity
US-2015274782-A1 · Oct 1, 2015 · US
PTEN binding compounds, formulations, and uses thereof
US10669241B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10669241-B2 |
| Application number | US-201916265662-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 1, 2019 |
| Priority date | Feb 17, 2017 |
| Publication date | Jun 2, 2020 |
| Grant date | Jun 2, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Described herein are compounds and formulations thereof that can bind PTEN. Also described herein are methods of using the compounds and formulations thereof that can bind PTEN. In some embodiments, the method can include administering an amount of a compound or formulation described herein to a subject in need thereof.
First claim
Opening claim text (preview).
We claim: 1. A compound having a structure according to Formula 1 where R 1 is H, where R 2 is where R 3 is where R 4 is or where R 3 and R 4 together form 2. The compound of claim 1 , wherein the compound is compound 15, 16, 17, 18, 19, 20, 21, 24, 25, 26, 27, 32, 33, 34, 35, or 47 C 78 H 116 N 16 O 11 S 2 (35) 3. The compound of claim 1 , wherein the compound is compound 5, 8, 9, 10, 11, 12, 13, 14, 38, 39, 40, or 43
Assignees
Inventors
Classifications
- C07D233/74Primary
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members · CPC title
of a saturated carbon skeleton containing rings · CPC title
substituted additionally by nitrogen atoms, e.g. tryptophane · CPC title
having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title
Antineoplastic agents · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10669241B2 cover?
- Described herein are compounds and formulations thereof that can bind PTEN. Also described herein are methods of using the compounds and formulations thereof that can bind PTEN. In some embodiments, the method can include administering an amount of a compound or formulation described herein to a subject in need thereof.
- Who is the assignee on this patent?
- Dave Vrushank G, Cai Jianfeng, Univ South Florida
- What technology area does this patent fall under?
- Primary CPC classification C07D233/74. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).